Home/ Stocks/ IVVD

Invivyd, Inc. Common Stock

IVVD XNAS

$1.50 +0.07 (+4.90%) ▲ 15-min delayed

Open

$1.43

High

$1.53

Low

$1.43

Volume

1.47M

Market Cap

$424.21M

About Invivyd, Inc. Common Stock

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 122 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$53.43M	$-52,489,000	$-0.30
FY 2025	$53.43M	$-52,489,000	$-0.30
Q3 2025	$13.13M	$-10,470,000	$-0.06
Q2 2025	$11.79M	$-14,660,000	$-0.12

Related Market News

No specific coverage for IVVD yet. Check out our latest market news or earnings calendar.

Get IVVD Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Invivyd, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.